Alexoff, David https://orcid.org/0000-0002-0612-1239
Ploessl, Karl
Zhao, Ruiyue
Li, Linlin
Kim, Dohyun
Zhu, Lin
Kung, Hank
Funding for this research was provided by:
Five Eleven Pharma Inc (Five Eleven Pharma Inc)
Article History
Received: 16 September 2025
Accepted: 20 October 2025
First Online: 17 November 2025
Declarations
:
: Not applicable.
: Not applicable.
: DA, and KP are employees of Five Eleven Pharma. HK is the founder and Chairman of the board at Five Eleven Pharma. DK has received fees as a consultant for Five Eleven Pharma. Other authors declare that they have no competing interests.